DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| HR Pharmaceuticals, LLC Life sciences | unattributed | 2 | at least $13.6M | 100c | 0 pts | Jan 29, 2031 | Mar 31, 2026 |
| C2DX, Inc Life sciences | unattributed | 2 | at least $13.6M | 100c | n/a | Mar 19, 2030 | Mar 31, 2024 |
| Eating Recovery Center ERC Topco Holdings, LLC Healthcare services | unattributed | 1 | at least $13.6M | 10c | n/a | Mar 29, 2030 | Dec 31, 2022 |
| J•• P•••••• I•• Healthcare services | unattributed | 2 | at least $13.5M | 99c | n/a | Feb 13, 2032 | Mar 31, 2025 |
| E••• F•••••• H•••••••• I•• Life sciences | unattributed | 4 | at least $13.5M | 101c | n/a | Apr 23, 2031 | Jun 30, 2024 |
| P••••••••• I•• Healthcare services | Sponsor not establishedpossible: R• C•••••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $13.5M | 101c | 0 pts | Feb 27, 2032 | Mar 31, 2026 |
| R•••• P••••••••• I•• Life sciences | unattributed | 1 | at least $13.5M | 100c | n/a | Sep 1, 2027 | Mar 31, 2022 |
| S••• B••••• I•• Healthcare services | unattributed | 2 | at least $13.5M | 100c | 0 pts | May 20, 2032 | Jun 30, 2026 |
| A••••••• P•••••••• P•••••••• L•• Healthcare services | unattributed | 3 | at least $13.5M | 0c | n/a | Dec 31, 2026 | Dec 31, 2021 |
| H••••• C••••••• I•• Healthcare services | unattributed | 1 | at least $13.4M | 104c | n/a | Jul 16, 2029 | Sep 30, 2024 |
| H• I•••• M••••• S••• I•• Life sciences | unattributed | 1 | at least $13.4M | 100c | n/a | May 31, 2033 | Jun 30, 2026 |
| N•••• B•••• Life sciences | unattributed | 2 | at least $13.3M | 99c | 0 pts | Jun 24, 2032 | Jun 30, 2025 |
| I• V•••• S••••••• L•• Healthcare services | unattributed | 2 | at least $13.2M | 100c | n/a | Feb 28, 2029 | Mar 31, 2024 |
| L•••• H•• B••••• I•• Healthcare services | unattributed | 1 | at least $13.2M | 87c | n/a | Jan 21, 2030 | Mar 31, 2024 |
| S••••••••• I••••••••• Life sciences | unattributed | 1 | at least $13.1M | 101c | n/a | Dec 31, 2029 | Dec 31, 2022 |
| A•••••••• B•••• I•• Healthcare services | B•••• C•••••• A•••• M••••••••• L•• inferred | 1 | at least $13.1M | 100c | n/a | Feb 14, 2031 | Mar 31, 2025 |
| W••• C••••••••• B••••• L•• Life sciences | unattributed | 2 | at least $13.0M | 100c | 0 pts | Dec 20, 2032 | Dec 31, 2025 |
| S•• T••••••••• I•• Healthcare services | Sponsor not establishedpossible: R• C•••••• (a company of this name is on the sponsor's portfolio page) | 3 | at least $13.0M | 103c | n/a | Feb 28, 2029 | Mar 31, 2024 |
| R•• H••••• S••••••• P••• H••••• C••••••••• L•• Healthcare services | unattributed | 2 | at least $13.0M | 101c | 0 pts | Aug 2, 2027 | Dec 31, 2022 |
| S••••• H••••• H•••••••• L•• Life sciences | unattributed | 6 | at least $13.0M | 100c | n/a | May 30, 2031 | Mar 31, 2023 |
| L•••••••• H•••••• I•• Healthcare services | unattributed | 8 | at least $12.9M | 98c | 1 pts | Nov 30, 2028 | Dec 31, 2021 |
| H••• C••• A••••••••• L•• Healthcare services | unattributed | 4 | at least $12.9M | 85c | 3 pts | Mar 30, 2027 | Dec 31, 2021 |
| X••••• I•• Healthcare services · grade B | unattributed | 2 | at least $12.8M | 100c | n/a | Jul 31, 2031 | Dec 31, 2021 |
| T•••• L•••• I• S••• Life sciences | unattributed | 4 | at least $12.8M | 101c | 0 pts | Jun 12, 2031 | Jun 30, 2025 |
| I•• I••••••• S•••••••• I•• Distribution | unattributed | 5 | at least $12.7M | 102c | 3 pts | Jul 7, 2028 | Sep 30, 2022 |
| Q••• U• M•••• 2• L•••••• F••••••• B• Life sciences | unattributed | 1 | at least $12.7M | 100c | n/a | Jun 30, 2029 | Jun 30, 2026 |
| Q••••••• S•••••• Life sciences | unattributed | 1 | at least $12.7M | 100c | n/a | Sep 12, 2026 | Dec 31, 2025 |
| P•••••••• C•••••••• P••••••• P•••••• L•• Healthcare services | unattributed | 1 | at least $12.7M | 99c | n/a | Apr 16, 2032 | Jun 30, 2025 |
| S••••••••• D••••• H••••••• I•• L•• Healthcare services | unattributed | 2 | at least $12.6M | 101c | n/a | Nov 1, 2028 | Jun 30, 2024 |
| O••••• H••••• G••••• I•• Healthcare services | unattributed | 1 | at least $12.5M | 99c | n/a | Oct 1, 2029 | Dec 31, 2024 |
| C•••••• S••••••••• H•••••••• L•• Life sciences | unattributed | 1 | at least $12.4M | 100c | n/a | Jun 30, 2027 | Dec 31, 2022 |
| O••• T•• I••••••••• C••• Healthcare services | unattributed | 3 | at least $12.4M | 101c | n/a | Aug 6, 2032 | Dec 31, 2021 |
| A•••••• H•••••• L•• Healthcare services | unattributed | 13 | at least $12.3M | 100c | 0 pts | May 6, 2027 | Sep 30, 2021 |
| A••• D••••• P•••••••• L•• Healthcare services | unattributed | 3 | at least $12.3M | 100c | n/a | Oct 29, 2030 | Dec 31, 2022 |
| P•••••• T•••• T•••• M•••••• L•• Life sciences | unattributed | 2 | at least $12.2M | 99c | 0 pts | Jun 12, 2031 | Mar 31, 2026 |
| G••••• S•••• B••••• I•• Life sciences | unattributed | 7 | at least $12.1M | 100c | n/a | Apr 2, 2031 | Dec 31, 2021 |
| B••••• S••••••••• L••••• Life sciences | unattributed | 2 | at least $11.9M | 101c | n/a | Mar 25, 2028 | Jun 30, 2024 |
| C• M•••••• B• I•• A••••••••• L•• Life sciences | unattributed | 2 | at least $11.9M | 100c | 0 pts | Nov 1, 2027 | Dec 31, 2025 |
| P•••••••• • S•••••• O•••• H••••••••• O••••••••• H•••••••• I•• Healthcare services · Life sciences | unattributed | 1 | at least $11.9M | 97c | n/a | Apr 1, 2030 | Sep 30, 2025 |
| D••••••• L•• Healthcare services | unattributed | 3 | at least $11.9M | 100c | 3 pts | Dec 22, 2028 | Dec 31, 2022 |
| P••••••• O••••••• M•••• 2• L•• Life sciences | unattributed | 2 | at least $11.6M | 100c | 1 pts | Jul 17, 2028 | Dec 31, 2022 |
| H••••••••• V•••••• P•••••••• L•• Healthcare services | unattributed | 2 | at least $11.6M | 100c | n/a | Aug 29, 2030 | Sep 30, 2025 |
| A••••• P••••••••• L•• Life sciences | unattributed | 8 | at least $11.6M | 101c | n/a | Aug 1, 2032 | Jun 30, 2024 |
| I••••••••• I•• Healthcare services · Life sciences | unattributed | 1 | at least $11.5M | 109c | n/a | Feb 5, 2030 | Jun 30, 2026 |
| H••••••• P••••••• M••••••••• L•• Life sciences | unattributed | 1 | at least $11.5M | 101c | n/a | May 31, 2027 | Dec 31, 2022 |
| M•• H•••••••• L•• Healthcare services | unattributed | 2 | at least $11.4M | 112c | n/a | Sep 30, 2026 | Dec 31, 2021 |
| T•• S••••• B•••• Healthcare services | unattributed | 2 | at least $11.3M | 99c | 1 pts | Mar 27, 2028 | Dec 31, 2023 |
| B••••• H•••••• I•• Healthcare services | unattributed | 1 | at least $11.3M | 98c | n/a | Nov 1, 2029 | Dec 31, 2025 |
| M•••••• R••••• I•••••••• o• A•••••• Life sciences | Sponsor not establishedpossible: P•••••••• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 3 | at least $11.2M | 100c | 0 pts | Jul 31, 2030 | Mar 31, 2024 |
| P••••••• P••• G•••• B•••• L•••••• Healthcare services | unattributed | 1 | at least $11.1M | 109c | n/a | Nov 19, 2029 | Dec 31, 2022 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.